MMP9, matrix metallopeptidase 9, 4318

N. diseases: 1337; N. variants: 31
Disease: Recurrent tumor ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor 		0.040 Biomarker phenotype BEFREE The association between MMP-9, PTTG, HMGA2, and Ki-67 expression and clinicopathologic characteristics and tumor recurrence were evaluated. 29432944 2018
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor 		0.040 Biomarker phenotype BEFREE Increased expressions of both MIF (58.2%, 39/67) and MMP9 (55.2%, 37/67) were significantly associated with microvessel density (MVD) of tumor, but only dual high-expression of MIF and MMP9 was in relation to tumor invasion (P=0.016) and tumor recurrence (P=0.001). 23372434 2013
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor 		0.040 AlteredExpression phenotype BEFREE Clinically, high expression of matrix metalloproteinase 9 was associated with tumor recurrence (P < .001) and local invasion at the time of diagnosis (P = .018) among the extracellular matrix-related proteins, and was also associated with shorter recurrence-free survival (P = .025) in the patients with rhabdoid meningioma. 22995327 2013
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor 		0.040 AlteredExpression phenotype BEFREE Most importantly tumor recurrence was related with higher levels of both MMP-9 (p = 0.003) and IL-8 (p = 0.005). 22695075 2012